je.st
news
Vertex cystic fibrosis drug approved for another 500 U.S. patients
2014-12-29 22:34:29| Biotech - Topix.net
The U.S. Food and Drug Administration has approved Kalydeco by Vertex Pharmaceuticals for use in about 500 more cystic fibrosis patients than previously. Kalydeco is the Boston pharmaceutical company's only approved drug, following it's decision last year to discontinue its hepatitis C drug due to competition.
Tags: us
approved
drug
patients
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||